Tourmaline Composition of the Kı¸sladag Porphyry Au Deposit,Western Turkey: Implication of Epithermal Overprint

The Kışladağ porphyry Au deposit occurs in a middle Miocene magmatic complex comprising three different intrusions and magmatic-hydrothermal brecciation related to the multiphase effects of the different intrusions. Tourmaline occurrences are common throughout the deposit, mostly as an outer alteration rim around the veins with lesser amounts disseminated in the intrusions, and are associated with every phase of mineralization. Tourmaline mineralization has developed as a tourmaline-rich matrix in brecciated zones and tourmaline-quartz and/or tourmaline-sulfide veinlets within the different intrusive rocks. Tourmaline was identified in the tourmaline-bearing breccia zone (TBZ) and intrusive rocks that had undergone potassic, phyllic, and advanced argillic alteration. The tourmaline is present as two morphological varieties, aggregates of fine crystals (rosettes, fan-shaped) and larger isolated crystals and their aggregates. Four tourmaline generations (tourmaline I to IV) have different compositions and substitutions. Tourmaline I in TBZ and INT#1 is distinguished by the highest Fetot and enriched in Fe3+. Tourmalines II and III occur as fine aggregates, accompanied by the formation of isolated crystals and are characterized by lower Fetot and Fe3+. Tourmaline IV is characterized by the lowest Fetot, enriched in Cl, and has the highest proportion of X-site vacancy among all the tourmalines. Tourmaline I may be attributed to the potassic stage in INT#1 and early tourmaline in TBZ. Tourmalines II and III from INT#1 and the TBZ could be referred to the phyllic stage. The low Fe content in tourmaline is caused by the simultaneous deposition of sulfide minerals. Tourmaline IV from the TBZ and tourmaline II from INT#3 are distinguished by the high X-site vacancy proportion up to the formation of X-site vacant species as well as enriched in Cl; they can be attributed to the argillic stage of the hydrothermal process. The textural and especially chemical data of the tourmaline from the Kışladağ Au deposit provide information on the physico-chemical conditions during the porphyry to epithermal transition and subsequent epithermal overprinting

On renormalizability of the massless Thirring model

We discuss the renormalizability of the massless Thirring model in terms of the causal fermion Green functions and correlation functions of left-right fermion densities. We obtain the most general expressions for the causal two-point Green function and correlation function of left-right fermion densities with dynamical dimensions of fermion fields, parameterised by two parameters. The region of variation of these parameters is constrained by the positive definiteness of the norms of the wave functions of the states related to components of the fermion vector current. We show that the dynamical dimensions of fermion fields calculated for causal Green functions and correlation functions of left-right fermion densities can be made equal. This implies the renormalizability of the massless Thirring model in the sense that the ultra-violet cut-off dependence, appearing in the causal fermion Green functions and correlation functions of left-right fermion densities, can be removed by renormalization of the wave function of the massless Thirring fermion fields only.Comment: 17 pages, Latex, the contribution of fermions with opposite chirality is added,the parameterisation of fermion determinant by two parameters is confirmed,it is shown that dynamical dimensions of fermion fields calculated from different correlation functions can be made equal.This allows to remove the dependence on the ultra-violet cut-off by the renormalization of the wave function of Thirring fermion fields onl

Optimizing fire station locations for the Istanbul metropolitan municipality

Copyright @ 2013 INFORMSThe Istanbul Metropolitan Municipality (IMM) seeks to determine locations for additional fire stations to build in Istanbul; its objective is to make residences and historic sites reachable by emergency vehicles within five minutes of a fire station’s receipt of a service request. In this paper, we discuss our development of a mathematical model to aid IMM in determining these locations by using data retrieved from its fire incident records. We use a geographic information system to implement the model on Istanbul’s road network, and solve two location models—set-covering and maximal-covering—as what-if scenarios. We discuss 10 scenarios, including the situation that existed when we initiated the project and the scenario that IMM implemented. The scenario implemented increases the city’s fire station coverage from 58.6 percent to 85.9 percent, based on a five-minute response time, with an implementation plan that spans three years

On "full" twisted Poincare' symmetry and QFT on Moyal-Weyl spaces

We explore some general consequences of a proper, full enforcement of the "twisted Poincare'" covariance of Chaichian et al. [14], Wess [50], Koch et al. [34], Oeckl [41] upon many-particle quantum mechanics and field quantization on a Moyal-Weyl noncommutative space(time). This entails the associated braided tensor product with an involutive braiding (or $\star$-tensor product in the parlance of Aschieri et al. [3,4]) prescription for any coordinates pair of $x,y$ generating two different copies of the space(time); the associated nontrivial commutation relations between them imply that $x-y$ is central and its Poincar\'e transformation properties remain undeformed. As a consequence, in QFT (even with space-time noncommutativity) one can reproduce notions (like space-like separation, time- and normal-ordering, Wightman or Green's functions, etc), impose constraints (Wightman axioms), and construct free or interacting theories which essentially coincide with the undeformed ones, since the only observable quantities involve coordinate differences. In other words, one may thus well realize QM and QFT's where the effect of space(time) noncommutativity amounts to a practically unobservable common noncommutative translation of all reference frames.Comment: Latex file, 24 pages. Final version to appear in PR

Submucosal diclofenac for acute postoperative pain in third molar surgery: A randomized, controlled clinical trial

Diclofenac sodium is a widely used nonsteroidal anti-inflammatory drug (NSAID) for relief of inflammatory pain. A recent formulation combines this drug with hydroxypropyl-β-cyclodextrin (HPβCD) to improve its solubility and to enable subcutaneous administration. Previous studies confirmed the efficacy of this combination. This study’s aim was to evaluate the efficacy, safety, and local tolerability of diclofenac HPβCD administered as a local submucosal injection prior to lower third molar surgery. We conducted a prospective, randomized, double-blind, placebo-controlled, parallel-group phase II single-center study. Seventy-five patients requiring mandibular third molar surgery were randomized into 1 of 5 groups: 5 mg/1 mL diclofenac HPβCD, 12.5 mg/1 mL diclofenac HPβCD, 25 mg/1 mL diclofenac HPβCD, 50 mg/1 mL diclofenac HPβCD, or 1 mL placebo. The respective study drug was injected into the mucosal tissue surrounding the surgical site prior to surgery following achievement of local anesthesia. The primary outcome measure was the area under the curve (AUC) of cumulative pain scores from end of surgery to 6 h postsurgery. This demonstrated a global treatment effect between the active groups and placebo, hence confirming the study drug’s efficacy (P = 0.0126). Secondary outcome measures included the time until onset of pain and the time until patients required rescue medication, both showing statistical significance of the study drug compared to placebo (P < 0.0161 and P < 0.0001, respectively). The time until rescue medication ranged between 7.8 h (for 25 mg/1 mL diclofenac HPβCD) and 16 h (for 50 mg/1 mL diclofenac HPβCD). Interestingly, the 5-mg/1-mL solution appeared superior to the 12.5-mg/1-mL and 25-mg/1-mL solutions (time until rescue medication = 12.44 h). A total of 14% of patients experienced minor adverse drug reactions (ADRs), of which 2 cases demonstrated flap necrosis. These resolved without further intervention. The study results overall indicate efficacy, safety, and relative tolerability of diclofenac HPβCD used locally as a submucosal injection prior to third molar surgery (ClinicalTrials.gov NCT01706588)

Phase Structure and Compactness

In order to study the influence of compactness on low-energy properties, we compare the phase structures of the compact and non-compact two-dimensional multi-frequency sine-Gordon models. It is shown that the high-energy scaling of the compact and non-compact models coincides, but their low-energy behaviors differ. The critical frequency $\beta^2 = 8\pi$ at which the sine-Gordon model undergoes a topological phase transition is found to be unaffected by the compactness of the field since it is determined by high-energy scaling laws. However, the compact two-frequency sine-Gordon model has first and second order phase transitions determined by the low-energy scaling: we show that these are absent in the non-compact model.Comment: 21 pages, 5 figures, minor changes, final version, accepted for publication in JHE

Genome-Wide Transcriptional Reorganization Associated with Senescence-to-Immortality Switch during Human Hepatocellular Carcinogenesis

Cataloged from PDF version of article.Senescence is a permanent proliferation arrest in response to cell stress such as DNA damage. It contributes strongly to tissue aging and serves as a major barrier against tumor development. Most tumor cells are believed to bypass the senescence barrier (become "immortal") by inactivating growth control genes such as TP53 and CDKN2A. They also reactivate telomerase reverse transcriptase. Senescence-to-immortality transition is accompanied by major phenotypic and biochemical changes mediated by genome-wide transcriptional modifications. This appears to happen during hepatocellular carcinoma (HCC) development in patients with liver cirrhosis, however, the accompanying transcriptional changes are virtually unknown. We investigated genome-wide transcriptional changes related to the senescence-to-immortality switch during hepatocellular carcinogenesis. Initially, we performed transcriptome analysis of senescent and immortal clones of Huh7 HCC cell line, and identified genes with significant differential expression to establish a senescence-related gene list. Through the analysis of senescence-related gene expression in different liver tissues we showed that cirrhosis and HCC display expression patterns compatible with senescent and immortal phenotypes, respectively; dysplasia being a transitional state. Gene set enrichment analysis revealed that cirrhosis/senescence-associated genes were preferentially expressed in non-tumor tissues, less malignant tumors, and differentiated or senescent cells. In contrast, HCC/immortality genes were up-regulated in tumor tissues, or more malignant tumors and progenitor cells. In HCC tumors and immortal cells genes involved in DNA repair, cell cycle, telomere extension and branched chain amino acid metabolism were up-regulated, whereas genes involved in cell signaling, as well as in drug, lipid, retinoid and glycolytic metabolism were down-regulated. Based on these distinctive gene expression features we developed a 15-gene hepatocellular immortality signature test that discriminated HCC from cirrhosis with high accuracy. Our findings demonstrate that senescence bypass plays a central role in hepatocellular carcinogenesis engendering systematic changes in the transcription of genes regulating DNA repair, proliferation, differentiation and metabolism

PPAR-alpha L162V polymorphism in human hepatocellular carcinoma

Background/aims: Several lines of evidence suggest that peroxisome proliferator-activated receptor alpha may be involved in hepatocarcinogenesis. L162V polymorphism of the peroxisome proliferator-activated receptor alpha gene enhances the transactivation activity of this transcription factor. The aim of this study was to determine the frequency and clinical correlates of peroxisome proliferator-activated receptor alpha L162V polymorphism in hepatitis virus-induced hepatocellular carcinoma. Methods: 90 hepatocellular carcinoma patients diagnosed at Ankara University Gastroenterology Clinic between January 2002 and July 2003 and 80 healthy controls with normal body mass index, blood chemistry and with negative viral serology were included. peroxisome proliferator-activated receptor alpha L162V polymorphism was determined by PCR-RFLP. Results: hepatocellular carcinoma etiologies were as follows: 56 HBV, 12 HBV+HDV, 22 HCV. Eighty-seven patients (97%) were cirrhotic, and 60 patients (67.5%) had advanced tumors. In 83 (92%) of 90 hepatocellular carcinoma patients, gene segment including polymorphic region could be amplified by PCR (50 HBV, 12 HBV+HDV, 21 HCV) and 6 of them (7.2%, all infected with HBV) had L162V polymorphism, while 2 (2.5%) of 80 controls had this polymorphism (p=0.162). This trend became more remarkable when only HBV (HBV+HDV)-infected patients were compared with controls (6/62, 9.7% vs. 2/80, 2.5%, respectively, p=0.071). Five of 6 patients with L162V had advanced disease. Conclusions: Peroxisome proliferator-activated receptor alpha L162V polymorphism tends to occur in HBV-induced epatocellular carcinoma and is absent in HCV-related epatocellular carcinoma. These findings may show clues for the existence of different carcinogenesis mechanisms in these two common etiologies. Frequent occurrence of advanced disease in patients with L162V polymorphism suggests a role for this polymorphism in tumor progression